Zydus reduces COVID-19 drug Remdesivir price to Rs 899 Ruchika Sharma25 March 2021 1:51 PM ISTAhmedabad: In a significant move Zydus has made its brand of Remdesivir, Remdac more affordable at Rs. 899 for a 100 mg lyophilized injection....
Zydus Cadila secures USFDA nod for Nortriptyline Hydrochloride Capsules Ruchika Sharma27 Feb 2021 10:00 AM ISTAhmedabad: Drugmaker, Zydus Cadila, has recently announced that the company has received final approval from the USFDA to market Nortriptyline...
Zydus Cadila secures USFDA nod for Droxidopa Capsules to treat low blood pressure Ruchika Sharma19 Feb 2021 1:05 PM ISTAhmedabad: Pharma major, Zydus Cadila, today announced that the company has received final approval from the USFDA to market Droxidopa Capsules, 100...
Zydus Cadila net profit rises 41 percent to Rs 527 crore in Q3 Ruchika Sharma8 Feb 2021 10:00 AM ISTAhmedabad: Pharmaceutical major Zydus Cadila said on Friday its profit after tax was up by 41 per cent to Rs 527 crore in Q3 FY21 as compared to the...
Zydus Cadila completes patient enrolment for 2 Phase III trials of Desidustat Ruchika Sharma6 Feb 2021 10:00 AM ISTAhmedabad: Zydus Cadila, global pharmaceutical company, has recently announced that the company has completed patient enrolment in DREAM-ND and...
Zydus Cadila completes Phase-I trials of single dose cure for Malaria Ruchika Sharma5 Feb 2021 12:53 PM ISTAhmedabad: Drugmaker, Zydus Cadila, has recently announced that the company's antimalarial compound ZY19489 (MMV253) in development with Swiss-based...
Zydus Cadila gets USFDA Orphan Drug Designation for Saroglitazar Mg to treat PBC Ruchika Sharma29 Jan 2021 12:11 PM ISTSaroglitazar Mg is a potent and selective peroxisome proliferator-activated receptor alpha and gamma dual agonist.
Zydus Cadila Desidustat shows efficacy, safety in treating Hypoxia in COVID-19 patients Ruchika Sharma26 Jan 2021 11:00 AM ISTAhmedabad: Drug major, Zydus Cadila, has recently announced that the company has received positive results from Phase 2(b) studies of Desidustat...
Zydus Cadila gets USFDA nod for Liothyronine Sodium Tablets to treat underactive thyroid Ruchika Sharma25 Jan 2021 11:36 AM ISTAhmedabad: Pharma major, Zydus Cadila, has recently announced that the company has received final approval from the United States Food &...
Zydus Cadila secures DCGI nod to start Phase III Clinical Trial of ZyCoV-D to prevent COVID Ruchika Sharma4 Jan 2021 12:28 PM ISTZyCoV-D was found to be safe, well tolerated and immunogenic in the Phase I/II clinical trials.
Zydus Cadila gets DCGI nod for Saroglitazar Mg for Non-alcoholic Fatty Liver Disease in India Ruchika Sharma31 Dec 2020 12:19 PM ISTWith a once daily, 4mg dose regimen, Saroglitazar Mg will enable better compliance, reduces the pill burden and offers the patient more convenience.
COVID vaccine ZyCoV-D found safe in clinical trials: Zydus Cadila MD Bureau25 Dec 2020 11:13 AM ISTAhmedabad: Zydus Cadila announced on Thursday that its plasmid DNA vaccine to prevent COVID-19 - ZyCoV-D - was found to be safe, well tolerated and...
